Lumos Diagnostics HoldingsASX:LDX 31 Quick Ratio is 0.63 as of Dec. 2025, which is 9% below its 10-year median of 0.69. GuruFocus rates ASX:LDX with a GF Score™ of 31/100 and a GF Value™ of A$0.02 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Lumos Diagnostics Holdings ranks worse than 89.47% on this metric.
Lumos Diagnostics Holdings has a quick ratio of 0.63. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Lumos Diagnostics Holdings's Quick Ratio or its related term are showing as below:
ASX:LDX'
s Quick Ratio Range Over the Past 10 Years
Min: 0.38 Med: 0.69 Max: 6.26
Current: 0.63
During the past 4 years, Lumos Diagnostics Holdings's highest Quick Ratio was 6.26. The lowest was 0.38. And the median was 0.69.
ASX:LDX's Quick Ratio is ranked worse than 89.47% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 1.86
vs ASX:LDX: 0.63
Lumos Diagnostics Holdings (ASX:LDX) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Lumos Diagnostics Holdings Quick Ratio Related Terms
Lumos Diagnostics Holdings Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Lumos Diagnostics Holdings's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumos Diagnostics Holdings Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lumos Diagnostics Holdings's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Lumos Diagnostics Holdings's Quick Ratio falls into.
Lumos Diagnostics Holdings Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumos Diagnostics Holdings (ASX:LDX) has a Quick Ratio of 0.63 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Lumos Diagnostics Holdings and its competitors. This is near median its historical median of 0.69. Over the past decade, Lumos Diagnostics Holdings' Quick Ratio has ranged from 0.38 to 6.26. According to the industry distribution chart, Lumos Diagnostics Holdings ranks #765 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 89.5%.
Is Lumos Diagnostics Holdings' Quick Ratio too high?
Lumos Diagnostics Holdings' current Quick Ratio of 0.63 is near median its 10-year median of 0.69. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 6.26. The Medical Devices & Instruments industry median Quick Ratio is 1.86. Lumos Diagnostics Holdings' value of 0.63 is 66.1% below this industry median. Based on the distribution chart, Lumos Diagnostics Holdings ranks #765 out of 855 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Lumos Diagnostics Holdings has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lumos Diagnostics Holdings' Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Lumos Diagnostics Holdings ranks #765 out of 855 companies for Quick Ratio. This places Lumos Diagnostics Holdings in the lower half of its industry. The industry median Quick Ratio is 1.86. Lumos Diagnostics Holdings' value of 0.63 is 66.1% below this benchmark. Historically, Lumos Diagnostics Holdings' own Quick Ratio has ranged from 0.38 to 6.26 over the past decade. While the company's 10-year median is 0.69 vs. the industry median of 1.86, Lumos Diagnostics Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.86, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lumos Diagnostics Holdings's current Quick Ratio of 0.63 is 66.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Lumos Diagnostics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumos Diagnostics Holdings's current Quick Ratio is 0.63, which is near median its own 10-year median of 0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumos Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Lumos Diagnostics Holdings (ASX:LDX) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.11 — trading 425% above its estimated fair value. The current Quick Ratio is 0.63, which is near median its 10-year median of 0.69 and 66.1% below the Medical Devices & Instruments industry median of 1.86. Lumos Diagnostics Holdings' overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Lumos Diagnostics Holdings (ASX:LDX), the current Quick Ratio is 0.63 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lumos Diagnostics Holdings (ASX:LDX) Overvalued in 2026?
Based on GuruFocus' analysis, Lumos Diagnostics Holdings stock appears to be overvalued.
The current stock price of A$0.11 is trading 425% above its estimated GF Value™ of A$0.02.
GuruFocus considers Lumos Diagnostics Holdings to be Significantly Overvalued.
Key valuation signals for ASX:LDX:
Quick Ratio: 0.63 (near median its 10-year median of 0.69)
GF Value™: A$0.02 vs. price of A$0.11 (425% above fair value)
Industry Position: 66.1% below the Medical Devices & Instruments median (#765 of 855)
No single metric tells the full story. See the ASX:LDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture, and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. The group is dedicated to providing contract research and development services, focusing on the innovation, development, manufacturing, and commercialization of point-of-care diagnostic solutions for both clinical and consumer applications. It generates maximum revenue from commercial services and solutions relating to POC diagnostic tests. The group has one operating segment, which is the provision of point-of-care diagnostics goods and services. The Company operates in two geographical regions, the United States and Australia and the majority of revenue is generated from the United States.
31GF Score
Get the complete analysis for ASX:LDX
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:LDX has been successfully added to your 
